Non-inferiority results: everything you need know in 5 mnutes!

  Рет қаралды 23,670

Michael Fralick

Michael Fralick

3 жыл бұрын

This was recorded in March 2020 and intended to help internal medicine residents as they study for their royal college exam.
If you'd like to receive more content relevant to internal medicine you can tune into our podcast: podcasts.apple.com/ca/podcast...
trialfiles.substack.com/

Пікірлер: 28
@dannidiestro
@dannidiestro 3 жыл бұрын
Amazing!
@rohanphilip665
@rohanphilip665 Жыл бұрын
Very clear and concise! Thanks
@Fralickmike
@Fralickmike Жыл бұрын
You’re welcome!
@jamesleem.d.7442
@jamesleem.d.7442 Жыл бұрын
SUPERB presentation.
@Fralickmike
@Fralickmike Жыл бұрын
Thank you !!
@Milad_showcase
@Milad_showcase 3 жыл бұрын
Really nice and clear explanation, thanks Michael, really helpful
@Fralickmike
@Fralickmike 2 жыл бұрын
thank you!
@CreamPieMyFace3
@CreamPieMyFace3 Жыл бұрын
beautifully explained. thank you so much
@Fralickmike
@Fralickmike Жыл бұрын
You're most welcome
@potatonail7463
@potatonail7463 2 жыл бұрын
Really great! Thankyou
@Fralickmike
@Fralickmike 2 жыл бұрын
you are most welcome
@TheVishu27
@TheVishu27 Жыл бұрын
One of the best 👍💯
@Fralickmike
@Fralickmike Жыл бұрын
Thank you!
@amohadjel
@amohadjel Жыл бұрын
Incredible!
@Fralickmike
@Fralickmike Жыл бұрын
Thank you!!
@DethWench
@DethWench Жыл бұрын
Great video! Very helpful slides!
@Fralickmike
@Fralickmike Жыл бұрын
Thank you!
@aritrasaha7421
@aritrasaha7421 2 жыл бұрын
Very helpful, Thank you.
@Fralickmike
@Fralickmike Жыл бұрын
Glad it was helpful!
@sarahashmori8999
@sarahashmori8999 Жыл бұрын
THANK YOU!!!
@Fralickmike
@Fralickmike Жыл бұрын
You’re most welcome
@junlizhu2312
@junlizhu2312 2 жыл бұрын
'The noninferiority and inferiority' one makes sense but feels weird lol. Thanks for the wonderful explanation!
@Fralickmike
@Fralickmike 2 жыл бұрын
You're very welcome!
@residentswap697
@residentswap697 2 жыл бұрын
Super helpful, thank you! Could you explain in words what a set margin of x (Let's say 20%), would mean? 20% acceptable difference between groups? still struggling with that concept , thanks!
@Fralickmike
@Fralickmike 2 жыл бұрын
Our generic ASA is non-inferior to brand name ASA at preventing a heart attack. Oh really? What margin did you set. 20%! And what did your study show? It showed that the upper bound of the confidence interval was only 19%. OK cool, then it sounds like your generic ASA is truly non-inferior.
@ivytruong4997
@ivytruong4997 11 ай бұрын
how do you set the 20% margin on the forest plot?
@rh2996
@rh2996 Жыл бұрын
Does the margin line must be drawn in the graph? Because I’ve seen in many articles it is not in the graph
@Fralickmike
@Fralickmike Жыл бұрын
You are right it is often not written in the figure at all. I like to include it when I’m explaining this study design as I find it makes the whole concept easier to understand
Calculation of Equivalence and Non Inferiority Margin in Clinical Trial
20:02
Clinical Pharmacology with Dr Maulik S. Doshi
Рет қаралды 4,2 М.
Stupid Barry Find Mellstroy in Escape From Prison Challenge
00:29
Garri Creative
Рет қаралды 21 МЛН
1❤️#thankyou #shorts
00:21
あみか部
Рет қаралды 88 МЛН
I CAN’T BELIEVE I LOST 😱
00:46
Topper Guild
Рет қаралды 57 МЛН
Confounding: Everything you need to know in 5 minutes!
5:30
Michael Fralick
Рет қаралды 73
Confounding
10:28
Elizabeth Lynch
Рет қаралды 198 М.
ECG crash course in 7min for nurses and medical students
7:43
Michael Fralick
Рет қаралды 1,1 М.
Interpreting Hazard Ratios
5:01
Terry Shaneyfelt
Рет қаралды 329 М.
EBM Tutorial - Non-Inferiority Trials
11:50
iForumRx
Рет қаралды 32 М.
Non-Inferiority Trial
11:24
CCM Academics
Рет қаралды 2,1 М.
Ozempic (semaglutide): Everything you need to know in 5 minutes
5:13
How to Interpret and Use a Relative Risk and an Odds Ratio
11:00
Terry Shaneyfelt
Рет қаралды 359 М.
How to interpret clinical trial data - Examples from recent clinical trials
37:30
European Society of Cardiology
Рет қаралды 43 М.
Stupid Barry Find Mellstroy in Escape From Prison Challenge
00:29
Garri Creative
Рет қаралды 21 МЛН